Live from the NIH registry
Studies recruiting near San Francisco right now
Top 25 of 2,228 recruiting studies, sorted by proximity — each links to its official registry page
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
University of California San Francisco Medical Center — San Francisco, California (1.9 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
Osteoporotic Fractures, Osteoporosis
N/A
Observational 648 participants sought
University of California San Francisco (USCF) Department of Orthopaedic Surgery — San Francisco, California (1.9 mi)
· Sponsor: AO Foundation, AO Spine
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: GentiBio, Inc
Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physical Therapy Clinics
Postpartum Bladder Dysfunction, Post-prostatectomy Bladder Dysfunction
N/A
Observational 25 participants sought
University of California San Francisco Weill Institute for Neurosciences — San Francisco, California (1.9 mi)
· Sponsor: University of California, San Francisco
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center — San Francisco, California (1.9 mi)
· Sponsor: Relay Therapeutics, Inc.
Treatment of Moderate to Severe Refractory Crohn's Disease
Crohns Disease
Phase 1, Phase 2
Interventional 39 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: Tr1X, Inc.
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Advanced Thyroid Gland Medullary Carcinoma, Stage III Thyroid Gland Medullary Carcinoma AJCC v8
N/A
Observational 2,030 participants sought
University of California San Francisco — San Francisco, California (1.9 mi)
· Sponsor: M.D. Anderson Cancer Center
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Obesity
Phase 3
Interventional 600 participants sought
Diablo Clinical Research, Inc. — Walnut Creek, California (23.2 mi)
· Sponsor: Novo Nordisk A/S
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
University of California San Francisco — San Francisco, California (1.9 mi)
· Sponsor: Genentech, Inc.
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 1
Interventional 248 participants sought
University of California San Francisco Medical Center — San Francisco, California (1.9 mi)
· Sponsor: Nurix Therapeutics, Inc.
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Interstitial Lung Disease, Common Variable Immunodeficiency
Phase 2
Interventional 38 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: Children's Hospital Medical Center, Cincinnati
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
Stanford Hospitals and Clinics — Stanford, California (27.5 mi)
· Sponsor: Cook Research Incorporated
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Phase 1
Interventional 36 participants sought
Stanford University — Stanford, California (27.5 mi)
· Sponsor: PeproMene Bio, Inc.
Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells
EGFR Gene Mutation, Glioblastoma
Phase 1
Interventional 20 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: Hideho Okada, MD, PhD
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
East Bay Rheumatology Medical Group — San Leandro, California (15.9 mi)
· Sponsor: Crystalys Therapeutics
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
University of California San Francisco — San Francisco, California (1.9 mi)
· Sponsor: Takeda
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Diablo Clinical Research, Inc. — Walnut Creek, California (23.2 mi)
· Sponsor: Novo Nordisk A/S
Mirdametinib in Patients With Advanced NF1-mutant Melanoma
Advanced Unresectable Melanoma, Metastatic Melanoma
Phase 2
Interventional 10 participants sought
California Pacific Medical Center - Sutter Health — San Francisco, California (1.9 mi)
· Sponsor: Kevin Kim, MD
Type 1 Diabetes Extension Study
Type 1 Diabetes Mellitus, T1DM
N/A
Observational 111 participants sought
UCSF School of Medicine — San Francisco, California (1.9 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease
PD - Parkinson's Disease
N/A
Interventional 24 participants sought
University of California San Francisco — San Francisco, California (1.9 mi)
· Sponsor: University of California, San Francisco
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
Diablo Clinical Research, Inc. — Walnut Creek, California (23.2 mi)
· Sponsor: Novo Nordisk A/S
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis, Amyloid Cardiomyopathy
Phase 3
Interventional 587 participants sought
University of California, San Francisco (UCSF) — San Francisco, California (1.9 mi)
· Sponsor: Eidos Therapeutics, a BridgeBio company
iMOVE: Virtual Reality PT Versus Traditional PT
Physical Health
N/A
Interventional 40 participants sought
Lucile Packard Childrens Hospital Stanford — Palo Alto, California (27.3 mi)
· Sponsor: Stanford University
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Early Onset Alzheimer Disease, Alzheimer Disease
N/A
Observational 850 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: Indiana University
Wearable Activity Tracking to Curb Hospitalizations
Hematopoietic Neoplasm, Malignant Solid Neoplasm
N/A
Observational 260 participants sought
University of California, San Francisco — San Francisco, California (1.9 mi)
· Sponsor: University of California, San Francisco